The power of pills social, ethical and legal issues in drug development, marketing, and pricing /

Effective drug regulation a multicountry study /
od: Ratanawijitrasin, Sauwakon
Wydane: (2002)

Building a national framework for the establishment of regulatory science for drug development workshop summary /
Wydane: (2011)

Pharmaceutical reform a guide to improving performance and equity /
od: Roberts, Marc J.
Wydane: (2011)

Reputation and power organizational image and pharmaceutical regulation at the FDA
od: Carpenter, Daniel P., 1967-
Wydane: (2010)

Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
Wydane: (2009)

Pharmacy on a bicycle innovative solutions to global health and poverty /
od: Bing, Eric G.
Wydane: (2013)

A practical approach to pharmaceutical policy
od: Seiter, Andreas
Wydane: (2010)

The future of drug safety promoting and protecting the health of the public /
Wydane: (2007)

Incentives for global public health patent law and access to essential medicines /
Wydane: (2010)

Access to medicines and vaccines in the South : coherence of rules and policies applied by the European Union Commission /
od: Kingah, Stephen
Wydane: (2011)

Pharmaceutical pricing policies in a global market
Wydane: (2008)

The $800 million pill the truth behind the cost of new drugs /
od: Goozner, Merrill, 1950-
Wydane: (2004)

Of medicines and markets intellectual property and human rights in the free trade era /
od: Godoy, Angelina Snodgrass
Wydane: (2013)

Towards drugs of the future key issues in lead finding and lead optimization /
Wydane: (2008)

Drugs : from discovery to approval /
od: Ng, Rick
Wydane: (2015)

Les prix des medicaments sur un marche global politiques et enjeux.
Wydane: (2008)

The agile approach to adaptive research optimizing efficiency in clinical development /
od: Rosenberg, Michael J.
Wydane: (2010)

ADME-enabling technologies for drug design and development
Wydane: (2012)

Pharmaceutical blending and mixing /
Wydane: (2015)

Happy-people-pills for all
od: Walker, Mark (Mark Alan)
Wydane: (2013)

Innovation in the biopharmaceutical industry
Wydane: (2007)

Ghost-Managed Medicine : Big Pharma’s Invisible Hands /
od: Sismondo, Sergio
Wydane: (2018)

Negotiating health : intellectual property and access to medicines /
Wydane: (2006)

Drug discovery practices, processes, and perspectives /
Wydane: (2013)

Pharmaceutical industry innovation and developments /
Wydane: (2011)

Pills, power, and policy the struggle for drug reform in Cold War America and its consequences /
od: Tobbell, Dominique A., 1978-
Wydane: (2012)

Therapeutic targets modulation, inhibition, and activation /
Wydane: (2012)

Manufacturing of pharmaceutical proteins : from technology to economy /
od: Behme, Stefan
Wydane: (2015)

Profits before people? ethical standards and the marketing of prescription drugs /
od: Weber, Leonard J., 1942-
Wydane: (2006)

Outsourcing clinical development strategies for working with CROs and other partners /
Wydane: (2006)

Drug repositioning bringing new life to shelved assets and existing drugs /
Wydane: (2012)

Pharmaceutical economics and policy
od: Schweitzer, Stuart O.
Wydane: (2007)

Case studies in modern drug discovery and development
Wydane: (2012)

The art of drug synthesis
Wydane: (2007)

Modern drug synthesis
Wydane: (2010)

Successful drug discovery.
Wydane: (2015)